Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
New Ray Medicine International Holding Ltd. ( (HK:6108) ) has shared an update.
New Ray Medicine International Holding Ltd. announced the disposal of 801,000 Jiangxi Rimag shares on the open market, generating approximately HK$12.8 million. This transaction, classified as a discloseable transaction under Hong Kong’s Listing Rules, reflects the company’s strategic decision to divest its stake acquired as a cornerstone investor in Jiangxi Rimag, a medical imaging services provider in the PRC. The disposal may impact the company’s financial position and market strategy, while also influencing stakeholders’ perceptions of its investment decisions.
More about New Ray Medicine International Holding Ltd.
New Ray Medicine International Holding Ltd. is primarily engaged in the distribution and trading of pharmaceutical products and the provision of marketing and promotion services in the People’s Republic of China (PRC).
Average Trading Volume: 355,248
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$66.87M
Find detailed analytics on 6108 stock on TipRanks’ Stock Analysis page.